Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Ansquer

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2010
18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluationCatherine Ansquer, Sonia Scigliano, Eric Mirallié, et al.
Haematologica|January 2, 2008
18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's diseaseCatherine Ansquer, Thomas Hervouët, Anne Devillers, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 8, 2012
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)Françoise Kraeber-Bodéré, Pierre-Yves Salaun, Catherine Ansquer, et al.
Cancers|August 30, 2020
Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before SurgeryCatherine Ansquer, Delphine Drui, Eric Mirallié, et al.
Surgery|December 8, 2007
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinomaEric Mirallié, Thomas Guillan, Boumédiene Bridji, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2010
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinomaAmandine Pallardy, Caroline Bodet-Milin, Aurore Oudoux, et al.
Annals of Surgical Oncology|April 5, 2020
Utility of a Second <sup>99m</sup>Tc-MIBI Scintigraphy Before Reoperation for Patients With Persistent Sporadic Primary Hyperparathyroidism: Results of a Retrospective Multicenter StudySamuel Frey, Clément Couëtte, Christophe Trésallet, et al.
Arthritis Research & Therapy|November 19, 2020
Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patientsChristelle Darrieutort-Laffite, Catherine Ansquer, Hélène Aubert, et al.
Langenbeck'S Archives of Surgery|February 20, 2015
Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidismTristan Greilsamer, Claire Blanchard, Niki Christou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2023
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumoursDamian Wild, Henning Grønbæk, Shaunak Navalkissoor, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2010
18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluationCatherine Ansquer, Sonia Scigliano, Eric Mirallié, et al.
Haematologica|January 2, 2008
18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's diseaseCatherine Ansquer, Thomas Hervouët, Anne Devillers, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 8, 2012
Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)Françoise Kraeber-Bodéré, Pierre-Yves Salaun, Catherine Ansquer, et al.
Cancers|August 30, 2020
Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before SurgeryCatherine Ansquer, Delphine Drui, Eric Mirallié, et al.
Surgery|December 8, 2007
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinomaEric Mirallié, Thomas Guillan, Boumédiene Bridji, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2010
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinomaAmandine Pallardy, Caroline Bodet-Milin, Aurore Oudoux, et al.
Annals of Surgical Oncology|April 5, 2020
Utility of a Second <sup>99m</sup>Tc-MIBI Scintigraphy Before Reoperation for Patients With Persistent Sporadic Primary Hyperparathyroidism: Results of a Retrospective Multicenter StudySamuel Frey, Clément Couëtte, Christophe Trésallet, et al.
Arthritis Research & Therapy|November 19, 2020
Rheumatic involvement and bone scan features in Schnitzler syndrome: initial and follow-up data from a single-center cohort of 25 patientsChristelle Darrieutort-Laffite, Catherine Ansquer, Hélène Aubert, et al.
Langenbeck'S Archives of Surgery|February 20, 2015
Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidismTristan Greilsamer, Claire Blanchard, Niki Christou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2023
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumoursDamian Wild, Henning Grønbæk, Shaunak Navalkissoor, et al.
Pageof 5